Search for a command to run...
Panchsheel Organics Ltd. shows no revenue growth, profitability metrics, or efficiency ratios compared to its peers in the pharmaceuticals sector, making it a financially weak candidate in the current market. The overall performance of the company suggests significant underperformance in comparison to its peers, which exhibit strong growth and profitability.
Stocks | CMP | Market Cap | P/E | ROCE (%) | Debt/Equity |
---|---|---|---|---|---|
PANCHSHEEL | ₹154.45 | ₹203.44Cr | 14.75 | - | - |
SUNPHARMA | ₹1,563.35 | ₹3,75,099.26Cr | 87.59 | 17.60% | 0.04 |
DIVISLAB | ₹6,091.05 | ₹1,61,698.50Cr | 73.20 | 16.46% | - |
CIPLA | ₹1,587.60 | ₹1,28,217.27Cr | 23.73 | 22.77% | 0.01 |
TORNTPHARM | ₹3,581.55 | ₹1,21,215.77Cr | 61.53 | 24.28% | 0.57 |
DRREDDY | ₹1,280.30 | ₹1,06,835.27Cr | 15.50 | 26.86% | 0.07 |
MANKIND | ₹2,518.95 | ₹1,03,926.59Cr | 55.18 | 28.38% | 0.02 |